Tag

GSK

Is an adjuvant an excipient or an active ingredient? This was the central question in the Federal Court’s decision in GSK’s application...

GSK and Genentech settle Cabilly patent lawsuit

28 Mar 2012

Scott Beeser

GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech’s Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents. In...